Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis

Mcdonald, PP; Leifer, FG; Basso, J; Lasala, D; Li, DD; Chen, KJ; Zhang, JM; Perkins, WR; Cipolla, DC

Mcdonald, PP (通讯作者)，Insmed Inc, Dept Res, Bridgewater, NJ 08807 USA.

FRONTIERS IN IMMUNOLOGY, 2023; 14 ():

Abstract

Rheumatoid arthritis (RA) is a painful and incurable disease characterized by chronic joint inflammation and a progressive destruction of cartilage an......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索